Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
Journal Impact Factor (JIF 2025) – 2.5
Journal Citation Indicator (JCI 2025) – 0.40
Scopus CiteScore (2025) – 4.2
Index Copernicus Value (ICV 2024) – 161.00
MNiSW – 70 pts
ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download whole issue [PDF]

Contents – 2026, Vol. 35, No. 6 (June)

1
EditorialLaser dentistry; innovative technologies; quality of care

Academic mediator-driven research translation: The concept for making possible implementation

949-955

2
Meta-analysisOncology

Prognostic significance of ctDNA mutations in advanced HER2-positive breast cancer treated with targeted therapy: A meta-analysis

957-968

3
Original ArticleRehabilitation

Retrospective analysis of guideline-based massage therapy in primary care for musculoskeletal disorders

969-977

4
Original ArticleNuclear medicine and medical imaging; oncology; radiology

Impact of primary tumor SUVmax on PET accuracy in mediastinal lymph node staging of non-small cell lung cancer (NSCLC)

979-984

5
Original ArticleGastroenterology and hepatology; surgery; forensic pathology

The role of static and dynamic evaluation of sarcopenia in liver transplant candidates

985-995

6
Original ArticleOncology; infectious diseases; public health

Oncogenic impact of PIK3CA, KRAS, and PTEN mutations in cervical cancer among South Indian women

997-1008

7
Original ArticleOphthalmology

Association of lipid layer patterns with tear evaporation in smokers, refractive errors, and high body mass index

1009-1016

8
Original ArticlePediatric nephrology

Prediction model for postoperative urinary tract infection after unilateral pyeloplasty in children

1017-1025

9
Original ArticlePharmaceutical sciences; cardiology

Association between rivaroxaban use and acute kidney injury in patients over 65 years: A large-scale analysis of spontaneous reporting system data

1027-1035

10
Original ArticleBasic sciences; gastroenterology; molecular biology

Mendelian randomization analysis of metabolic blood biomarkers and gastrointestinal cancer risk

1037-1045

11
Original ArticleOncology

miR-145 inhibits colorectal cancer progression and metastasis by targeting SNAI1 and the cAMP/PKA pathway

1047-1061

12
Original ArticleEvidence-based healthcare; public health

Updating guidelines for the diagnosis of fetal alcohol spectrum disorders (FASD) in Poland

1063-1072

13
ReviewGastroenterology

Global, regional, and national burden of gastroesophageal reflux disease (GERD), 1990–2021, with projections to 2050

1073-1084

14
ReviewEndocrinology and metabolism; gastroenterology and hepatology

SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD): Mechanisms, clinical benefits, and outcomes

1085-1092

15
ReviewForensic toxicology; neurology; neuroscience; occupational diseases

Formaldehyde neurotoxicity: Effects on the mammalian brain, cognitive function, and neurodegenerative risk. A scoping review

1093-1107

16
ReviewEpidemiology; health policy and services; infectious diseases

Epidemiology of tuberculosis, scabies, and enteric infections in Polish prisons (2002–2023): A nationwide data analysis and systematic review

1109-1121